ALB and sarcopenia: Univariate analysis revealed a significant reduction in overall survival in patients with a prognostic nutritional index of <45, C-reactive protein-to-albumin ratio of ≥0.047, cancer antigen 19–9 levels of ≥130 U/mL, sarcopenia, lymph node metastasis, and vascular invasion.